top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Atlas of Ulcers in Systemic Sclerosis : Diagnosis and Management / / edited by Marco Matucci-Cerinic, Christopher P. Denton
Atlas of Ulcers in Systemic Sclerosis : Diagnosis and Management / / edited by Marco Matucci-Cerinic, Christopher P. Denton
Edizione [1st ed. 2019.]
Pubbl/distr/stampa Cham : , : Springer International Publishing : , : Imprint : Springer, , 2019
Descrizione fisica 1 online resource (224 pages)
Disciplina 616.544
Soggetto topico Rheumatology
Dermatology
Angiology
ISBN 3-319-98477-2
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Part I. Definition and Classification -- Chapter 1. Defining Digital Ulcers in Systemic Sclerosis - The State of the Art -- Chapter 2. Digital Ulcerations and Classification of SSc Subsets and Overlap Syndromes -- Chapter 3. Classification of Digital and Lower Limb Ulcers in SSc -- Part II. Pathobiology of Digital Ulcers -- Chapter 4. Vascular Mechanisms of Systemic Sclerosis -- Chapter 5. Introduction to Wound Healing and Tissue Repair -- Part III. Microvascular Modifications and Ulcers -- Chapter 6. Raynaud’s Phenomenon and Ulcers -- Chapter 7. Capillary Microscopy -- Chapter 8. Digital Ulcers, Vasculopathy and Internal Organ Involvement -- Part IV. Complications -- Chapter 9. Fistulas -- Chapter 10. Infections, Cellulitis and Osteomyelitis -- Chapter 11. Digital Loss (Gangrene, Amputation, Autoamputation) -- Chapter 12. Pain -- Chapter 13. Clinical Impact of Digital Ulcers -- Chapter 14. Calcinosis -- Part V. General Approach to Digital Ulceration – Algorithm -- Chapter 15. The Team and the Assessment -- Chapter 16. Diagnostic Tools -- Part VI. Differential Diagnosis -- Chapter 17. Differential Diagnosis – Vasculitis, Rheumatoid Arthritis, Behçet’s Disease, Thromboembolism -- Part VII. The Local Treatment of Skin Ulcers in Systemic Sclerosis -- Chapter 18. The Local Treatment – Methodology, Debridement and Wound Bed Preparation -- Chapter 19. Wound Dressing for Digital Ulcers in systemic sclerosis -- Part VIII . The Systemic Treatment of Skin Ulcers in Systemic Sclerosis -- Chapter 20. Ulcer Healing and Prevention in Systemic Sclerosis -- Chapter 21. Surgical Approaches Including Sympathectomy -- Chapter 22. Antibiotic Treatment -- Chapter 23. Alternative Therapeutic Approaches in Skin Ulcers Due to Systemic Sclerosis -- Part IX. Future Strategies - Regenerative Medicine -- Chapter 24. Adipose Derived Stem Cells to Facilitate Ulcer Healing - Future Strategies -- Part X. Atlas -- Chapter 25. Atlas of Digital Ulcers and Lesions.
Record Nr. UNINA-9910337517403321
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Scleroderma : From Pathogenesis to Comprehensive Management / / edited by John Varga, Christopher P. Denton, Fredrick M. Wigley, Yannick Allanore, Masataka Kuwana
Scleroderma : From Pathogenesis to Comprehensive Management / / edited by John Varga, Christopher P. Denton, Fredrick M. Wigley, Yannick Allanore, Masataka Kuwana
Edizione [2nd ed. 2017.]
Pubbl/distr/stampa Cham : , : Springer International Publishing : , : Imprint : Springer, , 2017
Descrizione fisica 1 online resource (XXXV, 743 p. 191 illus., 174 illus. in color.)
Disciplina 616.723
Soggetto topico Rheumatology
Respiratory organs—Diseases
Dermatology
Pneumology/Respiratory System
ISBN 3-319-31407-6
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Section I. Introduction -- Historical Perspective of Scleroderma -- Section II. Epidemiology, Genetics and Classification -- Epidemiology, Environmental and Infectious Risk Factors -- Genetic Factors -- Disease Subsets in Clinical Practice -- Evolving Concepts of Diagnosis and Classification -- Overlap Syndromes -- Juvenile Localized and Systemic Scleroderma -- Morphea (Localized Scleroderma) -- Scleroderma Mimics -- Systems Biology Approaches to Understanding the Pathogenesis of Systemic Sclerosis -- Section III: The Biological Basis of Systemic Sclerosis -- Introduction: The Etiopathogenesis of Systemic Sclerosis: An Integrated Overview -- Pathology of Systemic Sclerosis -- Inflammation and Immunity -- Autoantibodies as Markers and Possible Mediators of Scleroderma Pathogenesis -- The Clinical Aspects of Autoantibodies -- Mechanisms of Vascular Disease -- Biomarkers in Systemic Sclerosis -- Pathophysiology of Fibrosis in Systemic Sclerosis -- Overview of Animal Models -- Section IV. Cardiovascular Manifestations and Management -- Raynaud’s Phenomenon, Digital Ulcers, and Nailfold Capillaroscopy -- Renal Crisis and Other Renal Manifestations of Scleroderma -- Cardiac Involvement -- Section V. Pulmonary Manifestations and Management -- Overview of Lung Involvement: Diagnosis, Differential Diagnosis, and Monitoring -- Clinical Assessment of Lung Disease -- Treatment of Interstitial Lung Disease -- Pathogenesis of Pulmonary Arterial Hypertension -- Clinical Assessment of Pulmonary Hypertension -- The Management of Pulmonary Arterial Hypertension in the Setting of Systemic Sclerosis -- Section VI. Gastrointestinal Manifestations and Management -- Overview of Gastrointestinal Tract Involvement -- Upper Gastrointestinal Tract: Manifestations of Systemic Sclerosis -- Small and Large Intestinal Involvement and Nutritional Issues -- Section VII. Skin, Musculoskeletal and Other Complications -- Calcinosis -- Evaluation and Management of Skin Disease -- Assessment and Management of Progressive Skin Involvement in Diffuse Scleroderma -- Skeletal Muscle Involvement -- Tendons, Joints, and Bone -- Cancer in Systemic Sclerosis -- Overlooked Manifestations -- Pregnancy -- Section VIII: Management and Outcome Assessment -- Introduction to Section VIII: Management and Outcome Assessment -- Immunomodulatory, Immunoablative, and Biologic Therapies -- Investigative Approaches to Drug Therapy -- Drug Development and Regulatory Considerations for SSc Therapies -- Physical and Occupational Therapy -- Psychosocial Issues and Care for Patients with Systemic Sclerosis -- Clinical Trial Design in Systemic Sclerosis -- Measuring Disease Activity and Outcomes in Clinical Trials -- Innovative Approaches to Clinical Trials in Systemic Sclerosis -- Molecular Stratification by Gene Expression as a Paradigm for Precision Medicine in Systemic Sclerosis -- Section IX. Case Studies: Approach to Complex Clinical Problems -- Managing the Ischemic Finger in Scleroderma -- Scleroderma Renal Crisis -- Rapid Diffuse Skin Disease with Progressive Joint Contractures -- Management of the Scleroderma Patient with Pulmonary Arterial Hypertension Failing Initial Therapy -- Pseudo-obstruction with Malabsorption and Malnutrition -- Progressive Interstitial Lung Disease Non-Response to Cyclophosphamide -- Coping with the Disfigurement of Scleroderma: Facial, Skin, and Hand Changes -- Managing Complicated Digital Ulcers .
Record Nr. UNINA-9910149482403321
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2017
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui